NEXTURNBIOSCIENCE Co., Ltd. (KOSDAQ: 089140)
South Korea
· Delayed Price · Currency is KRW
2,835.00
-140.00 (-4.71%)
Dec 20, 2024, 9:00 AM KST
NEXTURNBIOSCIENCE Cash Flow Statement
Financials in millions KRW. Fiscal year is January - December.
Millions KRW. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2010 | 2009 - 2005 |
---|---|---|---|---|---|---|---|
Period Ending | Sep '24 Sep 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '10 Dec 31, 2010 | 2009 - 2005 |
Net Income | -23,630 | 9,681 | -4,688 | -4,433 | -2,436 | - | Upgrade
|
Depreciation & Amortization | 1,976 | 2,002 | 1,808 | 1,051 | 514.56 | - | Upgrade
|
Loss (Gain) From Sale of Assets | -83.53 | -57.76 | -2,351 | -23.71 | -0.95 | - | Upgrade
|
Asset Writedown & Restructuring Costs | - | 645 | - | - | - | - | Upgrade
|
Loss (Gain) From Sale of Investments | 8,444 | -24,816 | -1,057 | -2,160 | -343.42 | - | Upgrade
|
Loss (Gain) on Equity Investments | 20,537 | 3,524 | 4,873 | 5,227 | - | - | Upgrade
|
Provision & Write-off of Bad Debts | 118.08 | 77.26 | -92.67 | -114.86 | 1,458 | - | Upgrade
|
Other Operating Activities | -7,598 | 10,859 | -75.23 | 2,542 | -936.99 | - | Upgrade
|
Change in Accounts Receivable | -1,924 | -824.43 | -629.51 | 506.9 | 2,562 | - | Upgrade
|
Change in Inventory | -816.08 | 1,130 | 1,200 | 1,630 | 1,188 | - | Upgrade
|
Change in Accounts Payable | -926.87 | -1,254 | -679.12 | 229.68 | -2,191 | - | Upgrade
|
Change in Unearned Revenue | -10.53 | 0.26 | 7.09 | -40.02 | 40.02 | - | Upgrade
|
Change in Other Net Operating Assets | -1,229 | -2,937 | 494.64 | -750.74 | 381.65 | - | Upgrade
|
Operating Cash Flow | -5,142 | -1,971 | -1,191 | 3,664 | 235.94 | - | Upgrade
|
Operating Cash Flow Growth | - | - | - | 1453.13% | - | - | Upgrade
|
Capital Expenditures | -824.87 | -1,077 | -216.35 | -467.6 | -1,215 | - | Upgrade
|
Sale of Property, Plant & Equipment | -3,611 | 307.67 | 21,014 | 25.36 | 10.02 | - | Upgrade
|
Cash Acquisitions | - | - | -12,633 | - | - | - | Upgrade
|
Sale (Purchase) of Intangibles | 100.72 | 99.16 | -66.02 | -19.7 | -1.06 | - | Upgrade
|
Investment in Securities | -9,541 | -21,685 | 12,753 | -72,697 | 1,223 | - | Upgrade
|
Other Investing Activities | 46.81 | 39.9 | -392.46 | -92.19 | 0 | - | Upgrade
|
Investing Cash Flow | -8,932 | -17,417 | -56,511 | -73,251 | 16.63 | - | Upgrade
|
Long-Term Debt Issued | - | 21,046 | 66,510 | 40,857 | - | - | Upgrade
|
Total Debt Issued | 76,015 | 21,046 | 66,510 | 40,857 | - | - | Upgrade
|
Long-Term Debt Repaid | - | -4,760 | -22,467 | -3,389 | -25.84 | - | Upgrade
|
Total Debt Repaid | -69,557 | -4,760 | -22,467 | -3,389 | -25.84 | - | Upgrade
|
Net Debt Issued (Repaid) | 6,457 | 16,286 | 44,043 | 37,467 | -25.84 | - | Upgrade
|
Issuance of Common Stock | - | 999.99 | 4,206 | - | - | - | Upgrade
|
Repurchase of Common Stock | - | -81.24 | - | - | - | - | Upgrade
|
Dividends Paid | - | - | - | - | -1,069 | - | Upgrade
|
Other Financing Activities | 2,982 | 5,287 | -311.39 | -10.1 | - | - | Upgrade
|
Financing Cash Flow | 9,440 | 22,492 | 47,937 | 37,457 | -1,095 | - | Upgrade
|
Foreign Exchange Rate Adjustments | -190.85 | -11.15 | -223.57 | 61.85 | -691.53 | - | Upgrade
|
Miscellaneous Cash Flow Adjustments | 0 | 0 | - | - | - | - | Upgrade
|
Net Cash Flow | -4,825 | 3,093 | -9,989 | -32,068 | -1,534 | - | Upgrade
|
Free Cash Flow | -5,967 | -3,047 | -1,407 | 3,197 | -979.05 | - | Upgrade
|
Free Cash Flow Margin | -16.64% | -7.39% | -6.00% | 18.84% | -10.11% | - | Upgrade
|
Free Cash Flow Per Share | -579.74 | -302.11 | -207.29 | 498.56 | -152.68 | - | Upgrade
|
Cash Interest Paid | 3,673 | 3,333 | 2,232 | 205.83 | - | - | Upgrade
|
Cash Income Tax Paid | 3,508 | -25.64 | 405.86 | -845.73 | 1,216 | - | Upgrade
|
Levered Free Cash Flow | -25,087 | 5,481 | -17,895 | 15,606 | - | - | Upgrade
|
Unlevered Free Cash Flow | -21,675 | 8,029 | -14,353 | 17,116 | - | - | Upgrade
|
Change in Net Working Capital | 22,260 | -7,798 | 13,048 | -18,046 | - | - | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.